APOE/TOMM40 genetic loci, white matter hyperintensities, and cerebral microbleeds

International Journal of Stroke

Volumn 10, Issue 8, 2015, Pages 1297-1300

  Lyall, Donald M ^a   Maniega, Susana Muñoz ^a   Harris, Sarah E ^a   Bastin, Mark E ^a   Murray, Catherine ^a   Lutz, Michael W ^b   Saunders, Ann M ^b   Roses, Allen D ^b,c   Hernández, Maria del C Valdés ^a   Royle, Natalie A ^a   Starr, John M ^a   Porteous, David J ^a   Deary, Ian J ^a   Wardlaw, Joanna M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c Zinfandel Pharmaceuticals   (United States)

Author keywords

Brain microbleeds; Epidemiology; MRI; Neurology; Risk factors; Vascular events

Indexed keywords

APOLIPOPROTEIN E; CARRIER PROTEIN; TOMM40 PROTEIN, HUMAN;

AGED; ALZHEIMER DISEASE; APOE GENE; ARTICLE; BRAIN HEMORRHAGE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; IMAGING AND DISPLAY; MAJOR CLINICAL STUDY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TOMM40 GENE; WHITE MATTER HYPERINTENSITY; BRAIN; CEREBROVASCULAR DISORDERS; GENETIC PREDISPOSITION; GENETICS; LONGITUDINAL STUDY; PATHOLOGY; SCOTLAND; WHITE MATTER;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEINS E; BRAIN; CEREBROVASCULAR DISORDERS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MEMBRANE TRANSPORT PROTEINS; SCOTLAND; WHITE MATTER;

EID: 84954383681     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12615     Document Type: Article

References (25)

1. Stampfer MJ,. Cardiovascular disease and Alzheimer's disease: common links. J Intern Med 2006; 260:211-23.
2. Wardlaw JM, Smith EE, Biessels GJ,. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol 2013; 12:822-38.
3. Brickman AM, Siedlecki KL, Muraskin J,. White matter hyperintensities and cognition: Testing the reserve hypothesis. Neurobiol Aging 2011; 32:1588-98.
4. Roses AD, Lutz MW, Crenshaw DG, Grossman I, Saunders AM, Gottschalk WK,. TOMM40 and APOE: requirements for replication studies of association with age of disease onset and enrichment of a clinical trial. Alzheimers Dement 2013; 9:132-6.
5. Paternoster L, Chen W, Sudlow CLM,. Genetic determinants of white matter hyperintensities on brain scans: a systematic assessment of 19 candidate gene polymorphisms in 46 studies in 19,000 subjects. Stroke 2009; 40:2020-6.
6. Schilling S, DeStefano AL, Sachdev PS,. APOE genotype and MRI markers of cerebrovascular disease. Neurology 2013; 81:292-300.
7. Maxwell SS, Jackson CA, Paternoster L,. Genetic associations with brain microbleeds Systematic review and meta-analyses. Neurology 2011; 77:158-67.
8. Romero JR, Preis SR, Beiser A,. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study. Stroke 2014; 45:1492-4.
9. Caselli RJ, Dueck AC, Huentelman MJ,. Longitudinal modeling of cognitive aging and the TOMM40 effect. Alzheimers Dement 2012; 8:490-5.
10. Lutz MW, Crenshaw DG, Saunders AM, Roses AD,. Genetic variation at a single locus and age of onset for Alzheimer's disease. Alzheimers Dement 2010; 6:125-31.
11. Roses AD,. An inherited variable poly-T repeat genotype in TOMM40 in Alzheimer disease. Arch Neurol 2010; 67:536-41.
12. Deary IJ, Gow AJ, Taylor MD,. The Lothian Birth Cohort 1936: a study to examine influences on cognitive ageing from age 11 to age 70 and beyond. BMC Geriatr 2007; 7:28.
13. Wardlaw JM, Bastin ME, Valdés Hernández MC,. Brain aging, cognition in youth and old age and vascular disease in the Lothian Birth Cohort 1936: rationale, design and methodology of the imaging protocol. Int J Stroke 2011; 6:547-59.
14. Deary IJ, Gow AJ, Pattie A, Starr JM,. Cohort profile: the Lothian birth cohorts of 1921 and 1936. Int J Epidemiol 2012; 41:1576-84.
15. Linnertz C, Saunders AM, Lutz MW,. Characterization of the poly-t variant in the tomm40 gene in diverse populations. PLoS ONE 2012; 7:e30994.
16. Valdés Hernández MDC, Ferguson KJ, Chappell FM, Wardlaw JM,. New multispectral MRI data fusion technique for white matter lesion segmentation: method and comparison with thresholding in FLAIR images. Eur Radiol 2010; 20:1684-91.
17. Cordonnier C, Potter GM, Jackson CA,. Improving interrater agreement about brain microbleeds: development of the Brain Observer MicroBleed Scale (BOMBS). Stroke 2009; 40:94-9.
18. Bruno D, Nierenberg JJ, Ritchie JC, Lutz MW, Pomara N,. Cerebrospinal fluid cortisol concentrations in healthy elderly are affected by both APOE and TOMM40 variants. Psychoneuroendocrinology 2012; 37:366-71.
19. Folstein MF, Folstein SE, McHugh PR,. Mini-Mental State: a practical method for grading the state of patients for the clinician. J Psychiatr Res 1975; 12:189-98.
20. Tombaugh TN, McIntyre NJ,. The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 1992; 40:922-35.
21. Sveinbjornsdottir S, Sigurdsson S, Aspelund T,. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry 2008; 79:1002-6.
22. Jeerakathil T, Wolf PA, Beiser A,. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke 2004; 35:1831-5.
23. Hofer SM, Sliwinski MJ,. Understanding ageing: an evaluation of research designs for assessing the interdependence of ageing-related changes. Gerontology 2001; 47:341-52.
24. Lyall DM, Lopez LM, Bastin ME,. ADRB2, brain white matter integrity and cognitive ageing in the Lothian Birth Cohort 1936. Behav Genet 2013; 43:13-23.
25. Rosvall L, Rizzuto D, Wang HX, Winblad B, Graff C, Fratiglioni L,. APOE-related mortality: effect of dementia, cardiovascular disease and gender. Neurobiol Aging 2009; 30:1545-51.